NGS Streamlines Biomarker Testing in Solid Tumors

Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment planning in solid tumors.

Experts involved: Traina, MD, FASCO; Demetria Smith-Graziani, MD, MPH; Mark Agulnik, MD; Mrinal M. Zuckerman, MD.
Other contributors: Mark Agulnik, MD; Mrinal M. Kraveka, DO; Daniel Lefler, MD; Shaina A. Zuckerman, MD.
Additional experts: Naval G. Daver, MD; Jessica Altman, MD; Amir T. Roboz, MD; Joshua Zeidner, MD.
Further contributors: Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD; Anne Chiang, MD, PhD.
More experts: J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD; Zev A. Shah, MD, FASCO; Syma Iqbal, MD; Jennifer R.

No specific quotes are provided in the given text.

Author's summary: NGS improves biomarker testing in solid tumors.

Oncology Nursing News — 2025-10-27